Cortendo

Biotech · Acquired

Osilodrostat, a cortisol synthesis inhibitor molecule for treating Cushing's syndrome

cortendo.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3103TRIANGLE THERAPEUTICS INC.——
3104Thimble Therapeutics Inc——
3105EPIVAX, INC.——
3106Cortendo——
3107MICROPURE GENOMICS INC——
3108ERNEST PHARMACEUTICALS LLC——
3109MECHASIM INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.